{
  "ticker": "EW",
  "year": 2024,
  "quarter": 3,
  "last_updated": "2025-04-19T10:04:54.704574",
  "count": 110,
  "transactions": [
    {
      "id": 120797,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Markowitz Wayne",
      "reporting_owner_cik": "0001991414",
      "reporting_owner_position": "GM & SVP, Surgical",
      "transaction_date": "2024-09-14",
      "transaction_shares": "648.0000",
      "transaction_price": "68.5200",
      "transaction_type": "F",
      "shares_after_transaction": "10033.0463"
    },
    {
      "id": 147708,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Markowitz Wayne",
      "reporting_owner_cik": "0001991414",
      "reporting_owner_position": "GM & SVP, Surgical",
      "transaction_date": "2024-09-14",
      "transaction_shares": "648.0000",
      "transaction_price": "68.5200",
      "transaction_type": "F",
      "shares_after_transaction": "10033.0463"
    },
    {
      "id": 176709,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Markowitz Wayne",
      "reporting_owner_cik": "0001991414",
      "reporting_owner_position": "GM & SVP, Surgical",
      "transaction_date": "2024-09-14",
      "transaction_shares": "648.0000",
      "transaction_price": "68.5200",
      "transaction_type": "F",
      "shares_after_transaction": "10033.0463"
    },
    {
      "id": 208195,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Markowitz Wayne",
      "reporting_owner_cik": "0001991414",
      "reporting_owner_position": "GM & SVP, Surgical",
      "transaction_date": "2024-09-14",
      "transaction_shares": "648.0000",
      "transaction_price": "68.5200",
      "transaction_type": "F",
      "shares_after_transaction": "10033.0463"
    },
    {
      "id": 242200,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Markowitz Wayne",
      "reporting_owner_cik": "0001991414",
      "reporting_owner_position": "GM & SVP, Surgical",
      "transaction_date": "2024-09-14",
      "transaction_shares": "648.0000",
      "transaction_price": "68.5200",
      "transaction_type": "F",
      "shares_after_transaction": "10033.0463"
    },
    {
      "id": 279983,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Markowitz Wayne",
      "reporting_owner_cik": "0001991414",
      "reporting_owner_position": "GM & SVP, Surgical",
      "transaction_date": "2024-09-14",
      "transaction_shares": "648.0000",
      "transaction_price": "68.5200",
      "transaction_type": "F",
      "shares_after_transaction": "10033.0463"
    },
    {
      "id": 323144,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Markowitz Wayne",
      "reporting_owner_cik": "0001991414",
      "reporting_owner_position": "GM & SVP, Surgical",
      "transaction_date": "2024-09-14",
      "transaction_shares": "648.0000",
      "transaction_price": "68.5200",
      "transaction_type": "F",
      "shares_after_transaction": "10033.0463"
    },
    {
      "id": 369821,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Markowitz Wayne",
      "reporting_owner_cik": "0001991414",
      "reporting_owner_position": "GM & SVP, Surgical",
      "transaction_date": "2024-09-14",
      "transaction_shares": "648.0000",
      "transaction_price": "68.5200",
      "transaction_type": "F",
      "shares_after_transaction": "10033.0463"
    },
    {
      "id": 120777,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Dahl Andrew M.",
      "reporting_owner_cik": "0002022347",
      "reporting_owner_position": "SVP, Corporate Controller",
      "transaction_date": "2024-09-13",
      "transaction_shares": "2920.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "4690.7834"
    },
    {
      "id": 147687,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Dahl Andrew M.",
      "reporting_owner_cik": "0002022347",
      "reporting_owner_position": "SVP, Corporate Controller",
      "transaction_date": "2024-09-13",
      "transaction_shares": "2920.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "4690.7834"
    },
    {
      "id": 176688,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Dahl Andrew M.",
      "reporting_owner_cik": "0002022347",
      "reporting_owner_position": "SVP, Corporate Controller",
      "transaction_date": "2024-09-13",
      "transaction_shares": "2920.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "4690.7834"
    },
    {
      "id": 208173,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Dahl Andrew M.",
      "reporting_owner_cik": "0002022347",
      "reporting_owner_position": "SVP, Corporate Controller",
      "transaction_date": "2024-09-13",
      "transaction_shares": "2920.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "4690.7834"
    },
    {
      "id": 242178,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Dahl Andrew M.",
      "reporting_owner_cik": "0002022347",
      "reporting_owner_position": "SVP, Corporate Controller",
      "transaction_date": "2024-09-13",
      "transaction_shares": "2920.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "4690.7834"
    },
    {
      "id": 279957,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Dahl Andrew M.",
      "reporting_owner_cik": "0002022347",
      "reporting_owner_position": "SVP, Corporate Controller",
      "transaction_date": "2024-09-13",
      "transaction_shares": "2920.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "4690.7834"
    },
    {
      "id": 323117,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Dahl Andrew M.",
      "reporting_owner_cik": "0002022347",
      "reporting_owner_position": "SVP, Corporate Controller",
      "transaction_date": "2024-09-13",
      "transaction_shares": "2920.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "4690.7834"
    },
    {
      "id": 369794,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Dahl Andrew M.",
      "reporting_owner_cik": "0002022347",
      "reporting_owner_position": "SVP, Corporate Controller",
      "transaction_date": "2024-09-13",
      "transaction_shares": "2920.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "4690.7834"
    },
    {
      "id": 120789,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2024-09-11",
      "transaction_shares": "5000.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "51935.7184"
    },
    {
      "id": 147699,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2024-09-11",
      "transaction_shares": "5000.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "51935.7184"
    },
    {
      "id": 176700,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2024-09-11",
      "transaction_shares": "5000.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "51935.7184"
    },
    {
      "id": 208186,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2024-09-11",
      "transaction_shares": "5000.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "51935.7184"
    },
    {
      "id": 242191,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2024-09-11",
      "transaction_shares": "5000.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "51935.7184"
    },
    {
      "id": 279972,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2024-09-11",
      "transaction_shares": "5000.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "51935.7184"
    },
    {
      "id": 323133,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2024-09-11",
      "transaction_shares": "5000.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "51935.7184"
    },
    {
      "id": 369810,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2024-09-11",
      "transaction_shares": "5000.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "51935.7184"
    },
    {
      "id": 120781,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Szyman Catherine M.",
      "reporting_owner_cik": "0001438538",
      "reporting_owner_position": "CVP, Critical Care",
      "transaction_date": "2024-09-03",
      "transaction_shares": "10910.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "86817.4373"
    },
    {
      "id": 147691,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Szyman Catherine M.",
      "reporting_owner_cik": "0001438538",
      "reporting_owner_position": "CVP, Critical Care",
      "transaction_date": "2024-09-03",
      "transaction_shares": "10910.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "86817.4373"
    },
    {
      "id": 176692,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Szyman Catherine M.",
      "reporting_owner_cik": "0001438538",
      "reporting_owner_position": "CVP, Critical Care",
      "transaction_date": "2024-09-03",
      "transaction_shares": "10910.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "86817.4373"
    },
    {
      "id": 208177,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Szyman Catherine M.",
      "reporting_owner_cik": "0001438538",
      "reporting_owner_position": "CVP, Critical Care",
      "transaction_date": "2024-09-03",
      "transaction_shares": "10910.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "86817.4373"
    },
    {
      "id": 242182,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Szyman Catherine M.",
      "reporting_owner_cik": "0001438538",
      "reporting_owner_position": "CVP, Critical Care",
      "transaction_date": "2024-09-03",
      "transaction_shares": "10910.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "86817.4373"
    },
    {
      "id": 279961,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Szyman Catherine M.",
      "reporting_owner_cik": "0001438538",
      "reporting_owner_position": "CVP, Critical Care",
      "transaction_date": "2024-09-03",
      "transaction_shares": "10910.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "86817.4373"
    },
    {
      "id": 323121,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Szyman Catherine M.",
      "reporting_owner_cik": "0001438538",
      "reporting_owner_position": "CVP, Critical Care",
      "transaction_date": "2024-09-03",
      "transaction_shares": "10910.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "86817.4373"
    },
    {
      "id": 369798,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Szyman Catherine M.",
      "reporting_owner_cik": "0001438538",
      "reporting_owner_position": "CVP, Critical Care",
      "transaction_date": "2024-09-03",
      "transaction_shares": "10910.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "86817.4373"
    },
    {
      "id": 95887,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Chopra Daveen",
      "reporting_owner_cik": "0001740963",
      "reporting_owner_position": "CVP, TMTT",
      "transaction_date": "2024-08-20",
      "transaction_shares": "1250.0000",
      "transaction_price": "69.9501",
      "transaction_type": "S",
      "shares_after_transaction": "29333.0000"
    },
    {
      "id": 120799,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Chopra Daveen",
      "reporting_owner_cik": "0001740963",
      "reporting_owner_position": "CVP, TMTT",
      "transaction_date": "2024-08-20",
      "transaction_shares": "1250.0000",
      "transaction_price": "69.9501",
      "transaction_type": "S",
      "shares_after_transaction": "29333.0000"
    },
    {
      "id": 147710,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Chopra Daveen",
      "reporting_owner_cik": "0001740963",
      "reporting_owner_position": "CVP, TMTT",
      "transaction_date": "2024-08-20",
      "transaction_shares": "1250.0000",
      "transaction_price": "69.9501",
      "transaction_type": "S",
      "shares_after_transaction": "29333.0000"
    },
    {
      "id": 176711,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Chopra Daveen",
      "reporting_owner_cik": "0001740963",
      "reporting_owner_position": "CVP, TMTT",
      "transaction_date": "2024-08-20",
      "transaction_shares": "1250.0000",
      "transaction_price": "69.9501",
      "transaction_type": "S",
      "shares_after_transaction": "29333.0000"
    },
    {
      "id": 208197,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Chopra Daveen",
      "reporting_owner_cik": "0001740963",
      "reporting_owner_position": "CVP, TMTT",
      "transaction_date": "2024-08-20",
      "transaction_shares": "1250.0000",
      "transaction_price": "69.9501",
      "transaction_type": "S",
      "shares_after_transaction": "29333.0000"
    },
    {
      "id": 242202,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Chopra Daveen",
      "reporting_owner_cik": "0001740963",
      "reporting_owner_position": "CVP, TMTT",
      "transaction_date": "2024-08-20",
      "transaction_shares": "1250.0000",
      "transaction_price": "69.9501",
      "transaction_type": "S",
      "shares_after_transaction": "29333.0000"
    },
    {
      "id": 279985,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Chopra Daveen",
      "reporting_owner_cik": "0001740963",
      "reporting_owner_position": "CVP, TMTT",
      "transaction_date": "2024-08-20",
      "transaction_shares": "1250.0000",
      "transaction_price": "69.9501",
      "transaction_type": "S",
      "shares_after_transaction": "29333.0000"
    },
    {
      "id": 323146,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Chopra Daveen",
      "reporting_owner_cik": "0001740963",
      "reporting_owner_position": "CVP, TMTT",
      "transaction_date": "2024-08-20",
      "transaction_shares": "1250.0000",
      "transaction_price": "69.9501",
      "transaction_type": "S",
      "shares_after_transaction": "29333.0000"
    },
    {
      "id": 369823,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Chopra Daveen",
      "reporting_owner_cik": "0001740963",
      "reporting_owner_position": "CVP, TMTT",
      "transaction_date": "2024-08-20",
      "transaction_shares": "1250.0000",
      "transaction_price": "69.9501",
      "transaction_type": "S",
      "shares_after_transaction": "29333.0000"
    },
    {
      "id": 95904,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2024-08-14",
      "transaction_shares": "5000.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "51935.7184"
    },
    {
      "id": 120816,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2024-08-14",
      "transaction_shares": "5000.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "51935.7184"
    },
    {
      "id": 147727,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2024-08-14",
      "transaction_shares": "5000.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "51935.7184"
    },
    {
      "id": 176728,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2024-08-14",
      "transaction_shares": "5000.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "51935.7184"
    },
    {
      "id": 208215,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2024-08-14",
      "transaction_shares": "5000.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "51935.7184"
    },
    {
      "id": 242220,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2024-08-14",
      "transaction_shares": "5000.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "51935.7184"
    },
    {
      "id": 280007,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2024-08-14",
      "transaction_shares": "5000.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "51935.7184"
    },
    {
      "id": 323168,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2024-08-14",
      "transaction_shares": "5000.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "51935.7184"
    },
    {
      "id": 369846,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2024-08-14",
      "transaction_shares": "5000.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "51935.7184"
    },
    {
      "id": 73154,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lippis Daniel J.",
      "reporting_owner_cik": "0002004380",
      "reporting_owner_position": "CVP, JAPAC",
      "transaction_date": "2024-07-11",
      "transaction_shares": "500.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "23689.0651"
    },
    {
      "id": 95938,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lippis Daniel J.",
      "reporting_owner_cik": "0002004380",
      "reporting_owner_position": "CVP, JAPAC",
      "transaction_date": "2024-07-11",
      "transaction_shares": "500.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "23689.0651"
    },
    {
      "id": 120850,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lippis Daniel J.",
      "reporting_owner_cik": "0002004380",
      "reporting_owner_position": "CVP, JAPAC",
      "transaction_date": "2024-07-11",
      "transaction_shares": "500.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "23689.0651"
    },
    {
      "id": 147761,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lippis Daniel J.",
      "reporting_owner_cik": "0002004380",
      "reporting_owner_position": "CVP, JAPAC",
      "transaction_date": "2024-07-11",
      "transaction_shares": "500.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "23689.0651"
    },
    {
      "id": 176763,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lippis Daniel J.",
      "reporting_owner_cik": "0002004380",
      "reporting_owner_position": "CVP, JAPAC",
      "transaction_date": "2024-07-11",
      "transaction_shares": "500.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "23689.0651"
    },
    {
      "id": 208253,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lippis Daniel J.",
      "reporting_owner_cik": "0002004380",
      "reporting_owner_position": "CVP, JAPAC",
      "transaction_date": "2024-07-11",
      "transaction_shares": "500.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "23689.0651"
    },
    {
      "id": 242260,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lippis Daniel J.",
      "reporting_owner_cik": "0002004380",
      "reporting_owner_position": "CVP, JAPAC",
      "transaction_date": "2024-07-11",
      "transaction_shares": "500.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "23689.0651"
    },
    {
      "id": 280049,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lippis Daniel J.",
      "reporting_owner_cik": "0002004380",
      "reporting_owner_position": "CVP, JAPAC",
      "transaction_date": "2024-07-11",
      "transaction_shares": "500.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "23689.0651"
    },
    {
      "id": 323213,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lippis Daniel J.",
      "reporting_owner_cik": "0002004380",
      "reporting_owner_position": "CVP, JAPAC",
      "transaction_date": "2024-07-11",
      "transaction_shares": "500.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "23689.0651"
    },
    {
      "id": 369892,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lippis Daniel J.",
      "reporting_owner_cik": "0002004380",
      "reporting_owner_position": "CVP, JAPAC",
      "transaction_date": "2024-07-11",
      "transaction_shares": "500.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "23689.0651"
    },
    {
      "id": 73114,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2024-07-10",
      "transaction_shares": "5000.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "51935.7184"
    },
    {
      "id": 73144,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Feinberg David T",
      "reporting_owner_cik": "0001486426",
      "reporting_owner_position": null,
      "transaction_date": "2024-07-10",
      "transaction_shares": "2308.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "2308.0000"
    },
    {
      "id": 95897,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2024-07-10",
      "transaction_shares": "5000.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "51935.7184"
    },
    {
      "id": 95928,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Feinberg David T",
      "reporting_owner_cik": "0001486426",
      "reporting_owner_position": null,
      "transaction_date": "2024-07-10",
      "transaction_shares": "2308.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "2308.0000"
    },
    {
      "id": 120809,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2024-07-10",
      "transaction_shares": "5000.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "51935.7184"
    },
    {
      "id": 120840,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Feinberg David T",
      "reporting_owner_cik": "0001486426",
      "reporting_owner_position": null,
      "transaction_date": "2024-07-10",
      "transaction_shares": "2308.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "2308.0000"
    },
    {
      "id": 147720,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2024-07-10",
      "transaction_shares": "5000.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "51935.7184"
    },
    {
      "id": 147751,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Feinberg David T",
      "reporting_owner_cik": "0001486426",
      "reporting_owner_position": null,
      "transaction_date": "2024-07-10",
      "transaction_shares": "2308.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "2308.0000"
    },
    {
      "id": 176721,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2024-07-10",
      "transaction_shares": "5000.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "51935.7184"
    },
    {
      "id": 176752,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Feinberg David T",
      "reporting_owner_cik": "0001486426",
      "reporting_owner_position": null,
      "transaction_date": "2024-07-10",
      "transaction_shares": "2308.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "2308.0000"
    },
    {
      "id": 208208,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2024-07-10",
      "transaction_shares": "5000.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "51935.7184"
    },
    {
      "id": 208241,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Feinberg David T",
      "reporting_owner_cik": "0001486426",
      "reporting_owner_position": null,
      "transaction_date": "2024-07-10",
      "transaction_shares": "2308.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "2308.0000"
    },
    {
      "id": 242213,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2024-07-10",
      "transaction_shares": "5000.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "51935.7184"
    },
    {
      "id": 242247,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Feinberg David T",
      "reporting_owner_cik": "0001486426",
      "reporting_owner_position": null,
      "transaction_date": "2024-07-10",
      "transaction_shares": "2308.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "2308.0000"
    },
    {
      "id": 279998,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2024-07-10",
      "transaction_shares": "5000.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "51935.7184"
    },
    {
      "id": 280036,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Feinberg David T",
      "reporting_owner_cik": "0001486426",
      "reporting_owner_position": null,
      "transaction_date": "2024-07-10",
      "transaction_shares": "2308.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "2308.0000"
    },
    {
      "id": 323159,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2024-07-10",
      "transaction_shares": "5000.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "51935.7184"
    },
    {
      "id": 323200,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Feinberg David T",
      "reporting_owner_cik": "0001486426",
      "reporting_owner_position": null,
      "transaction_date": "2024-07-10",
      "transaction_shares": "2308.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "2308.0000"
    },
    {
      "id": 369837,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2024-07-10",
      "transaction_shares": "5000.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "51935.7184"
    },
    {
      "id": 369879,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Feinberg David T",
      "reporting_owner_cik": "0001486426",
      "reporting_owner_position": null,
      "transaction_date": "2024-07-10",
      "transaction_shares": "2308.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "2308.0000"
    },
    {
      "id": 73100,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lemercier Jean-Luc M",
      "reporting_owner_cik": "0001710625",
      "reporting_owner_position": "CVP, EMEACLA and JAPAC",
      "transaction_date": "2024-07-07",
      "transaction_shares": "82.0000",
      "transaction_price": "92.3200",
      "transaction_type": "F",
      "shares_after_transaction": "184685.8054"
    },
    {
      "id": 73119,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lippis Daniel J.",
      "reporting_owner_cik": "0002004380",
      "reporting_owner_position": "CVP, JAPAC",
      "transaction_date": "2024-07-07",
      "transaction_shares": "410.0000",
      "transaction_price": "92.3200",
      "transaction_type": "F",
      "shares_after_transaction": "23189.0651"
    },
    {
      "id": 73132,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Szyman Catherine M.",
      "reporting_owner_cik": "0001438538",
      "reporting_owner_position": "CVP, Critical Care",
      "transaction_date": "2024-07-07",
      "transaction_shares": "258.0000",
      "transaction_price": "92.3200",
      "transaction_type": "F",
      "shares_after_transaction": "75907.4373"
    },
    {
      "id": 95882,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lemercier Jean-Luc M",
      "reporting_owner_cik": "0001710625",
      "reporting_owner_position": "CVP, EMEACLA and JAPAC",
      "transaction_date": "2024-07-07",
      "transaction_shares": "82.0000",
      "transaction_price": "92.3200",
      "transaction_type": "F",
      "shares_after_transaction": "184685.8054"
    },
    {
      "id": 95902,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lippis Daniel J.",
      "reporting_owner_cik": "0002004380",
      "reporting_owner_position": "CVP, JAPAC",
      "transaction_date": "2024-07-07",
      "transaction_shares": "410.0000",
      "transaction_price": "92.3200",
      "transaction_type": "F",
      "shares_after_transaction": "23189.0651"
    },
    {
      "id": 95916,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Szyman Catherine M.",
      "reporting_owner_cik": "0001438538",
      "reporting_owner_position": "CVP, Critical Care",
      "transaction_date": "2024-07-07",
      "transaction_shares": "258.0000",
      "transaction_price": "92.3200",
      "transaction_type": "F",
      "shares_after_transaction": "75907.4373"
    },
    {
      "id": 120793,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lemercier Jean-Luc M",
      "reporting_owner_cik": "0001710625",
      "reporting_owner_position": "CVP, EMEACLA and JAPAC",
      "transaction_date": "2024-07-07",
      "transaction_shares": "82.0000",
      "transaction_price": "92.3200",
      "transaction_type": "F",
      "shares_after_transaction": "184685.8054"
    },
    {
      "id": 120814,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lippis Daniel J.",
      "reporting_owner_cik": "0002004380",
      "reporting_owner_position": "CVP, JAPAC",
      "transaction_date": "2024-07-07",
      "transaction_shares": "410.0000",
      "transaction_price": "92.3200",
      "transaction_type": "F",
      "shares_after_transaction": "23189.0651"
    },
    {
      "id": 120828,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Szyman Catherine M.",
      "reporting_owner_cik": "0001438538",
      "reporting_owner_position": "CVP, Critical Care",
      "transaction_date": "2024-07-07",
      "transaction_shares": "258.0000",
      "transaction_price": "92.3200",
      "transaction_type": "F",
      "shares_after_transaction": "75907.4373"
    },
    {
      "id": 147703,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lemercier Jean-Luc M",
      "reporting_owner_cik": "0001710625",
      "reporting_owner_position": "CVP, EMEACLA and JAPAC",
      "transaction_date": "2024-07-07",
      "transaction_shares": "82.0000",
      "transaction_price": "92.3200",
      "transaction_type": "F",
      "shares_after_transaction": "184685.8054"
    },
    {
      "id": 147725,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lippis Daniel J.",
      "reporting_owner_cik": "0002004380",
      "reporting_owner_position": "CVP, JAPAC",
      "transaction_date": "2024-07-07",
      "transaction_shares": "410.0000",
      "transaction_price": "92.3200",
      "transaction_type": "F",
      "shares_after_transaction": "23189.0651"
    },
    {
      "id": 147739,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Szyman Catherine M.",
      "reporting_owner_cik": "0001438538",
      "reporting_owner_position": "CVP, Critical Care",
      "transaction_date": "2024-07-07",
      "transaction_shares": "258.0000",
      "transaction_price": "92.3200",
      "transaction_type": "F",
      "shares_after_transaction": "75907.4373"
    },
    {
      "id": 176704,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lemercier Jean-Luc M",
      "reporting_owner_cik": "0001710625",
      "reporting_owner_position": "CVP, EMEACLA and JAPAC",
      "transaction_date": "2024-07-07",
      "transaction_shares": "82.0000",
      "transaction_price": "92.3200",
      "transaction_type": "F",
      "shares_after_transaction": "184685.8054"
    },
    {
      "id": 176726,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lippis Daniel J.",
      "reporting_owner_cik": "0002004380",
      "reporting_owner_position": "CVP, JAPAC",
      "transaction_date": "2024-07-07",
      "transaction_shares": "410.0000",
      "transaction_price": "92.3200",
      "transaction_type": "F",
      "shares_after_transaction": "23189.0651"
    },
    {
      "id": 176740,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Szyman Catherine M.",
      "reporting_owner_cik": "0001438538",
      "reporting_owner_position": "CVP, Critical Care",
      "transaction_date": "2024-07-07",
      "transaction_shares": "258.0000",
      "transaction_price": "92.3200",
      "transaction_type": "F",
      "shares_after_transaction": "75907.4373"
    },
    {
      "id": 208190,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lemercier Jean-Luc M",
      "reporting_owner_cik": "0001710625",
      "reporting_owner_position": "CVP, EMEACLA and JAPAC",
      "transaction_date": "2024-07-07",
      "transaction_shares": "82.0000",
      "transaction_price": "92.3200",
      "transaction_type": "F",
      "shares_after_transaction": "184685.8054"
    },
    {
      "id": 208213,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lippis Daniel J.",
      "reporting_owner_cik": "0002004380",
      "reporting_owner_position": "CVP, JAPAC",
      "transaction_date": "2024-07-07",
      "transaction_shares": "410.0000",
      "transaction_price": "92.3200",
      "transaction_type": "F",
      "shares_after_transaction": "23189.0651"
    },
    {
      "id": 208228,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Szyman Catherine M.",
      "reporting_owner_cik": "0001438538",
      "reporting_owner_position": "CVP, Critical Care",
      "transaction_date": "2024-07-07",
      "transaction_shares": "258.0000",
      "transaction_price": "92.3200",
      "transaction_type": "F",
      "shares_after_transaction": "75907.4373"
    },
    {
      "id": 242195,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lemercier Jean-Luc M",
      "reporting_owner_cik": "0001710625",
      "reporting_owner_position": "CVP, EMEACLA and JAPAC",
      "transaction_date": "2024-07-07",
      "transaction_shares": "82.0000",
      "transaction_price": "92.3200",
      "transaction_type": "F",
      "shares_after_transaction": "184685.8054"
    },
    {
      "id": 242218,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lippis Daniel J.",
      "reporting_owner_cik": "0002004380",
      "reporting_owner_position": "CVP, JAPAC",
      "transaction_date": "2024-07-07",
      "transaction_shares": "410.0000",
      "transaction_price": "92.3200",
      "transaction_type": "F",
      "shares_after_transaction": "23189.0651"
    },
    {
      "id": 242234,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Szyman Catherine M.",
      "reporting_owner_cik": "0001438538",
      "reporting_owner_position": "CVP, Critical Care",
      "transaction_date": "2024-07-07",
      "transaction_shares": "258.0000",
      "transaction_price": "92.3200",
      "transaction_type": "F",
      "shares_after_transaction": "75907.4373"
    },
    {
      "id": 279977,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lemercier Jean-Luc M",
      "reporting_owner_cik": "0001710625",
      "reporting_owner_position": "CVP, EMEACLA and JAPAC",
      "transaction_date": "2024-07-07",
      "transaction_shares": "82.0000",
      "transaction_price": "92.3200",
      "transaction_type": "F",
      "shares_after_transaction": "184685.8054"
    },
    {
      "id": 280004,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lippis Daniel J.",
      "reporting_owner_cik": "0002004380",
      "reporting_owner_position": "CVP, JAPAC",
      "transaction_date": "2024-07-07",
      "transaction_shares": "410.0000",
      "transaction_price": "92.3200",
      "transaction_type": "F",
      "shares_after_transaction": "23189.0651"
    },
    {
      "id": 280022,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Szyman Catherine M.",
      "reporting_owner_cik": "0001438538",
      "reporting_owner_position": "CVP, Critical Care",
      "transaction_date": "2024-07-07",
      "transaction_shares": "258.0000",
      "transaction_price": "92.3200",
      "transaction_type": "F",
      "shares_after_transaction": "75907.4373"
    },
    {
      "id": 323138,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lemercier Jean-Luc M",
      "reporting_owner_cik": "0001710625",
      "reporting_owner_position": "CVP, EMEACLA and JAPAC",
      "transaction_date": "2024-07-07",
      "transaction_shares": "82.0000",
      "transaction_price": "92.3200",
      "transaction_type": "F",
      "shares_after_transaction": "184685.8054"
    },
    {
      "id": 323165,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lippis Daniel J.",
      "reporting_owner_cik": "0002004380",
      "reporting_owner_position": "CVP, JAPAC",
      "transaction_date": "2024-07-07",
      "transaction_shares": "410.0000",
      "transaction_price": "92.3200",
      "transaction_type": "F",
      "shares_after_transaction": "23189.0651"
    },
    {
      "id": 323184,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Szyman Catherine M.",
      "reporting_owner_cik": "0001438538",
      "reporting_owner_position": "CVP, Critical Care",
      "transaction_date": "2024-07-07",
      "transaction_shares": "258.0000",
      "transaction_price": "92.3200",
      "transaction_type": "F",
      "shares_after_transaction": "75907.4373"
    },
    {
      "id": 369815,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lemercier Jean-Luc M",
      "reporting_owner_cik": "0001710625",
      "reporting_owner_position": "CVP, EMEACLA and JAPAC",
      "transaction_date": "2024-07-07",
      "transaction_shares": "82.0000",
      "transaction_price": "92.3200",
      "transaction_type": "F",
      "shares_after_transaction": "184685.8054"
    },
    {
      "id": 369843,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lippis Daniel J.",
      "reporting_owner_cik": "0002004380",
      "reporting_owner_position": "CVP, JAPAC",
      "transaction_date": "2024-07-07",
      "transaction_shares": "410.0000",
      "transaction_price": "92.3200",
      "transaction_type": "F",
      "shares_after_transaction": "23189.0651"
    },
    {
      "id": 369862,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Szyman Catherine M.",
      "reporting_owner_cik": "0001438538",
      "reporting_owner_position": "CVP, Critical Care",
      "transaction_date": "2024-07-07",
      "transaction_shares": "258.0000",
      "transaction_price": "92.3200",
      "transaction_type": "F",
      "shares_after_transaction": "75907.4373"
    }
  ]
}